Xiongbin Lu
Papers
1
Total Citations
8
H-Index
1
About
Xiongbin Lu is a leading researcher in urological oncology, with a primary focus on bladder cancer therapeutics and targeted drug delivery. His work harnesses the unique acidic microenvironment of tumors, pioneering the use of pH Low Insertion Peptides (pHLIPs) as smart delivery vehicles. In his highly cited 2022 study, Lu demonstrated that pHLIPs can effectively target bladder urothelial carcinoma cells, enabling the precise intracellular delivery of imaging agents like ICG and potent toxins like amanitin. This approach offers a paradigm shift from traditional chemotherapy by selectively killing cancer cells while sparing healthy tissue, directly addressing the high recurrence and progression rates of bladder cancer. With over 8 citations on this key paper alone, his contributions are shaping the future of non-invasive, image-guided therapy. Lu’s innovative work bridges the gap between tumor biology and clinical application, establishing him as a key figure in the development of next-generation, pH-responsive cancer treatments.
Research Focus
Key Achievements
Top Papers
- 1